Overview
Mirae Lee practices practicing medicine in Seoul, Republic of Korea.
Their clinical expertise encompasses Alzheimer's Disease, Glioblastoma, Astrocytoma, Dementia, and Tissue Biopsy.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mirae Lee
Is Mirae Lee a top-rated expert for Tissue Biopsy?
MediFind is an objective health platform that identifies experts based on real-world data. Mirae Lee is classified as an Experienced expert for Tissue Biopsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mirae Lee participate in research or clinical trials?
Yes. Mirae Lee has published 18 articles and abstracts on conditions like Tissue Biopsy. You can view a list of Mirae Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseLee isExperienced. Learn about Alzheimer's Disease.
- AstrocytomaLee isExperienced. Learn about Astrocytoma.
- DementiaLee isExperienced. Learn about Dementia.
- GlioblastomaLee isExperienced. Learn about Glioblastoma.
- Tissue BiopsyLee isExperienced. Learn about Tissue Biopsy.